Skip to main content

Volume 10 Supplement 1

Proceedings of the Seventh Scientific Meeting of The TMJ Association

  • Poster presentation
  • Open access
  • Published:

Association between INADL genetic variant and a subgroup with high risk for TMD in the OPPERA study


A major impediment to addressing the epidemic of persistent pain conditions is the development of classification procedures that capture the mosaic of signs and symptoms that accompany these disorders. According to the bio-psycho-social model, the measurable features of an idiopathic pain condition such as temporomandibular disorder (TMD) are associated with abnormalities in sensory, psychological, neuroimmune, and autonomic systems, which arise due to the interaction of genetic and environmental risk factors. Using a high-dimensional dataset derived from a large TMD case-control study, we have developed a new method to integrate clinically assessed intermediate phenotypes across bio-psycho-social domains, clustering subjects in a manner that provides clinically useful prognostic and diagnostic information. We performed a candidate gene association study to identify genes that influence cluster assignment in order to characterize the genetic determination of these clusters.

Materials and methods

Cluster analysis was performed to identify subgroups within the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study, which included 1,031 TMD cases and 3,247 controls. TMD status was confirmed using the Research Diagnostic Criteria for TMD (RDC/TMD); each participant was also assessed for psychological characteristics, medical history, and sensitivity to experimental pain. Supervised 3-means clustering was applied to the pain sensitivity and psychological data using the 15 features most strongly associated with TMD. Subjects were genotyped using a candidate gene panel of 2,924 single nucleotide polymorphisms (SNPs) corresponding to 358 pain-relevant genes. We assessed association between cluster identity and SNP genotypes using logistic regression.


In the contrast between Cluster 1 (n=1180, characterized by low pain sensitivity and low psychological distress) and Cluster 3 (n=273, high pain, high distress), the strongest association was with the SNP rs2498982 (minor allele frequency = 0.39), in the INADL gene (standardized OR=1.57, p=1.1x10-5). This gene is a scaffolding protein regulating tight junctions in sensory neurons, including interactions between channels involved in nociception such as ASIC3. No statistically significant (after Bonferroni correction) associations were observed in the contrast of Cluster 2 (n=1571, moderate pain, low distress) with Cluster 3 although the strongest signal (p=4.4x10-4) was again observed in INADL, indicating this gene may distinguish individuals in Cluster 3, with the highest risk of TMD. We also identified other genes potentially contributing to molecular pathways affecting cluster assignment.


Using a novel clustering method to classify individuals into diagnostic categories, we have identified a genetic variant in INADL associated with the subgroup with the highest risk for TMD.


Smith, Fillingim, Slade, Diatchenko, and Maixner declare financial relationships with Algynomics, Inc.


This work was supported by NIH grants U01DE017018, DE016558, P01NS045685, R01DE016155, and K12DE022793.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, S.B., Bair, E., Xue, W. et al. Association between INADL genetic variant and a subgroup with high risk for TMD in the OPPERA study. Mol Pain 10 (Suppl 1), P5 (2014).

Download citation

  • Published:

  • DOI: